Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

6505--Budesonide/Formoterol INH

Awarded
36E79726R0013Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract pertains to the supply of Budesonide/Formoterol oral inhalers in two strengths—160/4.5 mcg and 80/4.5 mcg—under a requirements-type indefinite-delivery, indefinite-quantity (IDIQ) arrangement administered by the Department of Veterans Affairs through its Pharmaceutical Prime Vendor program. The base performance period is one year, with four optional one-year extension periods, allowing the Government to extend delivery obligations up to five years total. Quantity commitments are fixed at 722,021 canisters annually for the 160/4.5 mcg strength and 220,295 canisters annually for the 80/4.5 mcg strength throughout the base and all option years. Pricing is not pre-determined and will be evaluated based on proposals submitted in response to the solicitation, with award made through a Lowest Price Technically Acceptable (LPTA) process. Offerors must meet strict technical acceptability criteria including FDA approval for the product, compliance with Current Good Manufacturing Practices (cGMP), provision of a unique and valid 11-digit National Drug Code (NDC), and demonstrated responsibility through past performance and facility clearance. Delivery is to VA and Department of Defense Prime Vendor distribution centers, with risk of loss transferring upon delivery to these designated contractors. All supplies must adhere to stringent packaging, labeling, and barcoding specifications aligned with GS1-128 or HIBCC standards, including the mandatory presence of a linear bar code on both outer and immediate containers, and a two-dimensional GS1 Data Matrix barcode on the lowest saleable unit as required by the Drug Supply Chain Security Act. Labels must include exact drug name and strength, the NDC number without over-labeling, and human-readable NDC adjacent to the bar code for compatibility with Veterans Affairs bar code medication administration systems. Stability testing and compliance with USP-NF and cGMP are required throughout the product lifecycle. The contractor must also submit a subcontracting plan under FAR 52.219-9 Alternate II and VAAR 852.219-70, with specific goals for Service-Disabled Veteran-Owned Small Business (SDVOSB) and Veteran-Owned Small Business (VOSB) participation, and is subject to liquidated damages for noncompliance. Multiple FAR and VA-specific clauses govern ethics, whistleblower rights, subcontractor restrictions, system maintenance, and procurement integrity, with all documentation

General Info

RFP for Budesonide/Formoterol inhalers supply to federal healthcare, one-year plus extensions.

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

3

RFP 36E79726R0013 Budesonide/Formoterol INH Pre-Solicitation Notice

DOCX, High priority: read this firstpresolicitation
High

SF 1449 Solicitation for Pharmaceutical Prime Vendor Contract

DOCX, High priority: read this first46 pages · rfp
High

VA Award Notice for Budesonide/Formoterol INH

DOCX, Low priority3 pages · award
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA
Contacts
Kenneth LayContract Specialist

Full Description

Show more
PRE-SOLICITATION NOTICE:  The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79726R0013 for an unrestricted procurement for Budesonide/Formoterol INH, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).  VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.  Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79726R0013 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about March 30, 2026, with a tentative closing date of April 13, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Kenneth Lay. Questions can be e-mailed to contact@example.gov.   The estimated annual requirements are as follows:  REQUIREMENT DESCRIPTION  ITEM  DESCRIPTION  PACKAGE SIZE (CANISTERS) TOTAL ESTIMATED ANNUAL USAGE (CANISTERS) 1 BUDESONIDE 160MCG/FORMOTEROL FUM 4.5MCG/SPRAY INHL,ORAL,10.2GM 1 722,021 2 BUDESONIDE 80MCG/FORMOTEROL FUM 4.5MCG/SPRAY INHL,ORAL,10.2GM 1 220,295

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
HYDROXYPROPYL METHYLCE
Solicitation # SPE2DP-27-T-0185
Solicitation SPE2DP-27-T-0185 is a Small Business Set-Aside request for the procurement of Ocucoat Viscoelastic 1ML, a 2% hydroxypropyl methylcellulose ophthalmic solution (NSN 6505016331037). This FDA-regulated medical device is designed for high-volume, small-incision cataract surgery and lens inserter lubrication. The requirement consists of 5 boxes, with a delivery timeline of 79 days after receipt of order and an original required delivery date of October 27, 2026. Delivery is FOB Destination, with the final destination located at the USA Med Mat Ctr EUR in Kaiserslautern, Germany. The contract mandates strict quality and shelf-life compliance, requiring a non-extendable shelf life of 24 months per RS016. Packaging must be commercial and sealed to prevent damage, adhering to MIL-STD-2073-1E and DLA packaging requirements. Marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for electronic invoicing and payment. The procurement is subject to various DFARS and FAR clauses, including the Buy American Act, safeguarding of covered defense information, and prohibitions on certain telecommunications equipment.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 24 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
EMOLLIENT LOTION
Solicitation # SPE2DP-27-T-0188
Solicitation SPE2DP-27-T-0188 is a procurement for emollient lotion under NAICS code 325412, managed by the Defense Logistics Agency. The requirement consists of multiple line items, including 500 bottles for CLIN 0001 and 12 bottles for CLIN 0002, with an additional 250 bottles for CLIN 0003. The product must be a non-sterile, homogeneous oil-in-water or water-in-oil emulsion with a pH range between 5.0 and 8.1 and a viscosity of 10,000 to 20,000 CPS. Each unit consists of a 240 ML (8 FL OZ) bottle equipped with a dispenser cap. The lotion must contain water, a suitable oil, an emulsifier, and a preservative, and it must be stored at controlled room temperature. Delivery is required within 20 days after the order, with specific required delivery dates ranging from June 17, 2026, to July 20, 2026. Shipments are designated as FOB Destination to various locations, including the USS George Washington, USS Iwo Jima, and the USNS Mercy. Packaging must comply with MIL-STD-129 and Medical Marking Standard No. 1, with non-hazardous materials following ASTM D3951 and hazardous materials adhering to TQ requirement IP025 and FED-STD-313. Palletization must follow DLA requirement RP001. The contract incorporates various FAR and DFARS clauses, including the Buy American Act, Wide Area Workflow for electronic payments, and destination inspection requirements.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 24 hours ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Pharmaceutical Preparation Manufacturing

POSTED

6 days ago

DEADLINE

in 6 days
View Details
NAICS: 325412
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Pharmaceutical Preparation Manufacturing

POSTED

12 days ago

DEADLINE

in 2 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS